Compare XLO & MBBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XLO | MBBC |
|---|---|---|
| Founded | 2016 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.4M | 33.5M |
| IPO Year | 2021 | N/A |
| Metric | XLO | MBBC |
|---|---|---|
| Price | $0.53 | $14.00 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 437.3K | 1.9K |
| Earning Date | 04-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,344,000.00 | N/A |
| Revenue This Year | $626.78 | N/A |
| Revenue Next Year | $79.08 | N/A |
| P/E Ratio | ★ N/A | $47.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.50 | $9.94 |
| 52 Week High | $1.18 | $14.64 |
| Indicator | XLO | MBBC |
|---|---|---|
| Relative Strength Index (RSI) | 39.47 | 61.97 |
| Support Level | $0.50 | $10.05 |
| Resistance Level | $0.74 | N/A |
| Average True Range (ATR) | 0.04 | 0.25 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 23.44 | 66.14 |
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.
Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.